{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:03:44Z","timestamp":1774591424893,"version":"3.50.1"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA034721"],"award-info":[{"award-number":["DA034721"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA007244"],"award-info":[{"award-number":["DA007244"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.bbi.2016.04.005","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T10:12:47Z","timestamp":1460283167000},"page":"325-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Acquisition of heroin conditioned immunosuppression requires IL-1 signaling in the dorsal hippocampus"],"prefix":"10.1016","volume":"56","author":[{"given":"Christina L.","family":"Lebonville","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan E.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee W.","family":"Hutson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letty B.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita A.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald T.","family":"Lysle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2016.04.005_b0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00006842-197403000-00011","article-title":"Behaviorally conditioned immunosuppression","volume":"36","author":"Ader","year":"1974","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.bbi.2016.04.005_b0010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00006842-197507000-00007","article-title":"Behaviorally conditioned immunosuppression","volume":"37","author":"Ader","year":"1975","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.bbi.2016.04.005_b0015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/bja\/aet153","article-title":"Opioids and immune modulation: more questions than answers","volume":"111","author":"Al-Hashimi","year":"2013","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.bbi.2016.04.005_b0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/clpt.2014.75","article-title":"Preserving learned immunosuppressive placebo response: perspectives for clinical application","volume":"96","author":"Albring","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbi.2016.04.005_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049477","article-title":"Placebo effects on the immune response in humans: the role of learning and expectation","volume":"7","author":"Albring","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2016.04.005_b0030","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/hipo.10135","article-title":"Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity","volume":"13","author":"Avital","year":"2003","journal-title":"Hippocampus"},{"key":"10.1016\/j.bbi.2016.04.005_b0035","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1699-0463.1993.tb00118.x","article-title":"Immunohistochemical localization of an inducible form of nitric oxide synthase in various organs of rats treated with Propionibacterium acnes and lipopolysaccharide","volume":"101","author":"Bandaletova","year":"1993","journal-title":"APMIS"},{"key":"10.1016\/j.bbi.2016.04.005_b0040","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bbi.2010.11.007","article-title":"Astrocytes support hippocampal-dependent memory and long-term potentiation via interleukin-1 signaling","volume":"25","author":"Ben Menachem-Zidon","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2016.04.005_b0045","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/ni1001-907","article-title":"Nitric oxide and the immune response","volume":"2","author":"Bogdan","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbi.2016.04.005_b0050","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1074\/mcp.M111.016121","article-title":"Morphine produces immunosuppressive effects in nonhuman primates at the proteomic and cellular levels","volume":"11","author":"Brown","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbi.2016.04.005_b0055","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S1286-4579(02)01612-X","article-title":"Structural and functional analyses of bacterial lipopolysaccharides","volume":"4","author":"Caroff","year":"2002","journal-title":"Microbes Infect."},{"key":"10.1016\/j.bbi.2016.04.005_b0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pharmthera.2012.01.008","article-title":"Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence","volume":"134","author":"Coller","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbi.2016.04.005_b0065","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0165-5728(94)90003-5","article-title":"Pavlovian conditioning of morphine-induced alterations of immune status: evidence for opioid receptor involvement","volume":"55","author":"Coussons-Read","year":"1994","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2016.04.005_b0070","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/brbi.1994.1019","article-title":"Pavlovian conditioning of morphine-induced alterations of immune status: evidence for peripheral beta-adrenergic receptor involvement","volume":"8","author":"Coussons-Read","year":"1994","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2016.04.005_b0075","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0165-5728(92)90256-K","article-title":"Pavlovian conditioning of morphine-induced alterations of immune status","volume":"39","author":"Coussons","year":"1992","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2016.04.005_b0080","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000323778","article-title":"Endocannabinergic modulation of interleukin-1beta in mouse hippocampus under basal conditions and after in vivo systemic lipopolysaccharide stimulation","volume":"18","author":"Csolle","year":"2011","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.bbi.2016.04.005_b0085","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1034\/j.1600-065x.2001.1840120.x","article-title":"Conditioning in the rat: an in vivo model to investigate the molecular mechanisms and clinical implications of brain-immune communication","volume":"184","author":"Exton","year":"2001","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbi.2016.04.005_b0090","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0165-5728(98)00122-2","article-title":"Behaviorally conditioned immunosuppression using cyclosporine A: central nervous system reduces IL-2 production via splenic innervation","volume":"88","author":"Exton","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2016.04.005_b0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0031-9384(97)00432-0","article-title":"Conditioned taste aversion produced by cyclosporine A: concomitant reduction in lymphoid organ weight and splenocyte proliferation","volume":"63","author":"Exton","year":"1998","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbi.2016.04.005_b0100","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/j.1460-9568.2007.05470.x","article-title":"Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212\u20132","volume":"25","author":"Fattore","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbi.2016.04.005_b0105","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0022-3565(25)12317-3","article-title":"Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats","volume":"276","author":"Fecho","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2016.04.005_b0110","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1096\/fj.02-0389com","article-title":"Behavioral conditioning of immunosuppression is possible in humans","volume":"16","author":"Goebel","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.bbi.2016.04.005_b0115","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.psyneuen.2007.09.004","article-title":"A dual role for interleukin-1 in hippocampal-dependent memory processes","volume":"32","author":"Goshen","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2016.04.005_b0120","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0022-3565(24)37665-7","article-title":"Alterations of immune functions in heroin addicts and heroin withdrawal subjects","volume":"286","author":"Govitrapong","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2016.04.005_b0125","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/1043-4666(92)90078-6","article-title":"Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans","volume":"4","author":"Granowitz","year":"1992","journal-title":"Cytokine"},{"key":"10.1016\/j.bbi.2016.04.005_b0130","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","article-title":"Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease","volume":"86","author":"Griffin","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2016.04.005_b0135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1086\/646004","article-title":"Increased incidence of infections in intravenous drug-users","volume":"10","author":"Horsburgh","year":"1989","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.bbi.2016.04.005_b0140","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1124\/pr.110.004135","article-title":"Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia","volume":"63","author":"Hutchinson","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbi.2016.04.005_b0145","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/npp.2014.317","article-title":"The role of brain interleukin-1 in stress-enhanced fear learning","volume":"40","author":"Jones","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2016.04.005_b0150","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1073\/pnas.072083799","article-title":"Molecular phenotyping for analyzing subtle genetic effects in mice: application to an angiotensinogen gene titration","volume":"99","author":"Kim","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2016.04.005_b0155","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1254\/jphs.FP0072106","article-title":"Immunosuppression induced by a conditioned stimulus associated with cocaine self-administration","volume":"107","author":"Kubera","year":"2008","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bbi.2016.04.005_b0160","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.4049\/jimmunol.0902436","article-title":"Arginase II restricts host defense to Helicobacter pylori by attenuating inducible nitric oxide synthase translation in macrophages","volume":"184","author":"Lewis","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2016.04.005_b0165","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.nbd.2014.11.021","article-title":"Toll-like receptor 4 enhancement of non-NMDA synaptic currents increases dentate excitability after brain injury","volume":"74","author":"Li","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2016.04.005_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-67-1-1","article-title":"The major medical complications of heroin addiction","volume":"67","author":"Louria","year":"1967","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbi.2016.04.005_b0175","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0165-5728(92)90014-C","article-title":"Evidence for the involvement of beta-adrenergic receptors in conditioned immunomodulation","volume":"38","author":"Luecken","year":"1992","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2016.04.005_b0180","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.brainres.2014.08.040","article-title":"Neuroinflammatory changes negatively impact on LTP: a focus on IL-1 beta","volume":"1621","author":"Lynch","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2016.04.005_b0185","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/0024-3205(88)90369-4","article-title":"Pavlovian conditioning of shock-induced suppression of lymphocyte reactivity: acquisition, extinction, and preexposure effects","volume":"42","author":"Lysle","year":"1988","journal-title":"Life Sci."},{"key":"10.1016\/j.bbi.2016.04.005_b0190","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0022-3565(25)13105-4","article-title":"Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status","volume":"277","author":"Lysle","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2016.04.005_b0195","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0162-3109(99)00172-1","article-title":"Heroin modulates the expression of inducible nitric oxide synthase","volume":"46","author":"Lysle","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.bbi.2016.04.005_b0200","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s00213-002-1208-x","article-title":"Heroin-associated environmental stimuli modulate the expression of inducible nitric oxide synthase in the rat","volume":"164","author":"Lysle","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2016.04.005_b0205","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0092-8674(95)90085-3","article-title":"Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase","volume":"81","author":"MacMicking","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2016.04.005_b0210","first-page":"123","article-title":"The hippocampus and contextual memory retrieval in Pavlovian fear conditioning","volume":"34","author":"Maren","year":"1999","journal-title":"Integr. Phys. Behav. Sci."},{"key":"10.1016\/j.bbi.2016.04.005_b0215","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0376-8716(00)00162-9","article-title":"The economic costs of heroin addiction in the United States","volume":"61","author":"Mark","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bbi.2016.04.005_b0220","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/jnr.23633","article-title":"Latent inhibition of conditioned taste aversion in rats with excitotoxic dorsal hippocampal lesions","volume":"93","author":"Molero-Chamizo","year":"2015","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbi.2016.04.005_b0225","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/fcp.12121","article-title":"The effect of various morphine weaning regimens on the sequelae of opioid tolerance involving physical dependency, anxiety and hippocampus cell neurodegeneration in rats","volume":"29","author":"Motaghinejad","year":"2015","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.bbi.2016.04.005_b0230","doi-asserted-by":"crossref","first-page":"8841","DOI":"10.1073\/pnas.97.16.8841","article-title":"Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens","volume":"97","author":"Nathan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2016.04.005_b0235","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000110639","article-title":"Central blockade of IL-1 does not impair taste-LPS associative learning","volume":"14","author":"Pacheco-Lopez","year":"2007","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.bbi.2016.04.005_b0240","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1523\/JNEUROSCI.4230-04.2005","article-title":"Neural substrates for behaviorally conditioned immunosuppression in the rat","volume":"25","author":"Pacheco-Lopez","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2016.04.005_b0245","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.bbi.2016.04.005_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-5728(95)00119-0","article-title":"Corticotropin-releasing hormone is involved in conditioned stimulus-induced reduction of natural killer cell activity but not in conditioned alterations in cytokine production or proliferation responses","volume":"63","author":"Perez","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2016.04.005_b0255","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1101\/lm.1.1.34","article-title":"Lesions of the dorsal hippocampal-formation interfere with background but not foreground contextual fear conditioning","volume":"1","author":"Phillips","year":"1994","journal-title":"Learn. Mem."},{"key":"10.1016\/j.bbi.2016.04.005_b0260","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0166-4328(01)00356-4","article-title":"The hippocampal debate: are we asking the right questions?","volume":"127","author":"Redish","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbi.2016.04.005_b0265","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0165-5728(97)00216-6","article-title":"Opiates and infection","volume":"83","author":"Risdahl","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2016.04.005_b0270","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jneuroim.2003.08.030","article-title":"A dual role for interleukin-1 in LTP in mouse hippocampal slices","volume":"144","author":"Ross","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2016.04.005_b0275","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1191\/0269216306pm1124oa","article-title":"Opioids and the immune system","volume":"20","author":"Sacerdote","year":"2006","journal-title":"Palliat. Med."},{"key":"10.1016\/j.bbi.2016.04.005_b0280","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.2174\/138161212803582496","article-title":"Non-analgesic effects of opioids: mechanisms and potential clinical relevance of opioid-induced immunodepression","volume":"18","author":"Sacerdote","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbi.2016.04.005_b0285","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.suronc.2009.03.007","article-title":"Drugs of anaesthesia and cancer","volume":"19","author":"Santamaria","year":"2010","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.bbi.2016.04.005_b0290","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1124\/jpet.108.148627","article-title":"Evidence for the nucleus accumbens as a neural substrate of heroin-induced immune alterations","volume":"329","author":"Saurer","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2016.04.005_b0295","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neulet.2008.03.052","article-title":"Effect of cytokines on neuronal excitability","volume":"437","author":"Schafers","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2016.04.005_b0300","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1124\/pr.114.009423","article-title":"Neuro-bio-behavioral mechanisms of placebo and nocebo responses: implications for clinical trials and clinical practice","volume":"67","author":"Schedlowski","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbi.2016.04.005_b0305","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbi.2009.08.007","article-title":"The learned immune response: Pavlov and beyond","volume":"24","author":"Schedlowski","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2016.04.005_b0310","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/hipo.20542","article-title":"The effects of IL-1 receptor antagonist on beta amyloid mediated depression of LTP in the rat CA1 in vivo","volume":"19","author":"Schmid","year":"2009","journal-title":"Hippocampus"},{"key":"10.1016\/j.bbi.2016.04.005_b0315","doi-asserted-by":"crossref","first-page":"7778","DOI":"10.1073\/pnas.95.13.7778","article-title":"A neuromodulatory role of interleukin-1beta in the hippocampus","volume":"95","author":"Schneider","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2016.04.005_b0320","doi-asserted-by":"crossref","first-page":"324","DOI":"10.5455\/medarh.2011.65.324-326","article-title":"Evaluation of circulating immune complexes and antiphospholipid antibodies (anti beta 2 glycoprotein 1) in heroin addicts and their clinical significance","volume":"65","author":"Simonovska","year":"2011","journal-title":"Med. Arh."},{"key":"10.1016\/j.bbi.2016.04.005_b0325","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0168-0102(00)00226-1","article-title":"The involvement of glial cells in the development of morphine tolerance","volume":"39","author":"Song","year":"2001","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.bbi.2016.04.005_b0330","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jneuroim.2011.06.002","article-title":"Ventral tegmental area-basolateral amygdala-nucleus accumbens shell neurocircuitry controls the expression of heroin-conditioned immunomodulation","volume":"237","author":"Szczytkowski","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2016.04.005_b0335","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bbi.2013.01.076","article-title":"Heroin-induced conditioned immunomodulation requires expression of IL-1beta in the dorsal hippocampus","volume":"30","author":"Szczytkowski","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2016.04.005_b0340","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00213-006-0673-z","article-title":"Conditioned effects of heroin on the expression of inducible nitric oxide synthase in the rat are susceptible to extinction and latent inhibition","volume":"191","author":"Szczytkowski","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2016.04.005_b0345","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1111\/j.1460-9568.2008.06472.x","article-title":"Conditioned effects of heroin on proinflammatory mediators require the basolateral amygdala","volume":"28","author":"Szczytkowski","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbi.2016.04.005_b0350","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneuroim.2010.05.029","article-title":"Dopamine D1 receptors within the basolateral amygdala mediate heroin-induced conditioned immunomodulation","volume":"226","author":"Szczytkowski","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2016.04.005_b0355","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00011-015-0857-2","article-title":"Role of nitric oxide in immune responses against viruses: beyond microbicidal activity","volume":"64","author":"Uehara","year":"2015","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bbi.2016.04.005_b0360","series-title":"Research Report Series: Heroin","author":"United States. National Institute on Drug Abuse","year":"2014"},{"key":"10.1016\/j.bbi.2016.04.005_b0365","series-title":"Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48","author":"United States. Substance Abuse and Mental Health Services Administration","year":"2014"},{"key":"10.1016\/j.bbi.2016.04.005_b0370","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.mjt.0000132250.95650.85","article-title":"Opioid therapy and immunosuppression: a review","volume":"11","author":"Vallejo","year":"2004","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.bbi.2016.04.005_b0375","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuropharm.2014.10.027","article-title":"Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability","volume":"96","author":"Vezzani","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2016.04.005_b0380","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0165-5728(98)00011-3","article-title":"Behaviorally conditioned effects of Cyclosporine A on the immune system of rats: specific alterations of blood leukocyte numbers and decrease of granulocyte function","volume":"85","author":"von Horsten","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2016.04.005_b0385","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1073\/pnas.1200130109","article-title":"Morphine activates neuroinflammation in a manner parallel to endotoxin","volume":"109","author":"Wang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2016.04.005_b0390","first-page":"447","article-title":"Initiating an enhanced recovery pathway program: an anesthesiology department\u2019s perspective","volume":"41","author":"Wu","year":"2015","journal-title":"Jt. Comm. J. Qual. Patient Saf."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159116300964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159116300964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:42:58Z","timestamp":1760168578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159116300964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":78,"alternative-id":["S0889159116300964"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2016.04.005","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquisition of heroin conditioned immunosuppression requires IL-1 signaling in the dorsal hippocampus","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2016.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}